Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Signal Transduction: Overview01:26

Signal Transduction: Overview

11.4K
Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
11.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.9K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

14.8K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

12.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
12.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GSK-3 regulates CD4-CD8 cooperation for super-armed CD8+ cytolytic T cells in immunotherapy against tumors.

Signal transduction and targeted therapy·2026
Same author

Comment on: Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation.

Cellular & molecular immunology·2025
Same author

GSK-3 regulates CD4-CD8 cooperation needed to generate super-armed CD8+ cytolytic T cells against tumors.

bioRxiv : the preprint server for biology·2025
Same author

Anti-PTHrP blockade limits CD8+ T-cell exhaustion in anti-cancer immunotherapy.

bioRxiv : the preprint server for biology·2024
Same author

Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression.

Acta neuropathologica·2024
Same author

The many faceted role of glycogen synthase kinase-3 (GSK-3) in T cells and cancer immunotherapy.

Journal of cancer biology·2024

Related Experiment Video

Updated: Jan 16, 2026

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.4K

CD19 structure, expression, and signaling: From basic mechanisms to therapeutic targeting.

Stéphane Schurmans1, Bastien Moës2

  • 1Laboratory of Functional Genetics, GIGA Institute, University of Liège, Avenue de l'Hôpital 11, 4000-Liège, Belgium.

Advances in Biological Regulation
|October 1, 2025
PubMed
Summary

CD19 regulates B-cell biology and immune responses. New findings reveal lipid-protein interactions control CD19 signaling, impacting B-cell development and offering therapeutic insights for autoimmune disorders and B-cell malignancies.

More Related Videos

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

11.8K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.3K

Related Experiment Videos

Last Updated: Jan 16, 2026

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.4K
Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

11.8K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.3K

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • CD19 is a crucial regulator of B-cell development, activation, and tolerance.
  • It functions as a signaling modulator and lineage marker, with its cytoplasmic domain interacting with PI3K.
  • CD19's expression and function are tightly controlled through various regulatory mechanisms and complex formation with CD21 and CD81.

Purpose of the Study:

  • To elucidate the regulatory mechanisms governing CD19 signaling.
  • To investigate the role of lipid-protein interactions in CD19 conformational control and activation.
  • To understand how dysregulation of CD19 impacts B-cell function and contributes to disease.

Main Methods:

  • Analysis of CD19 structure and function in B-cell biology.
  • Investigation of genetic studies in mice and humans to understand CD19's role as a molecular rheostat.
  • Exploration of lipid-protein interactions, specifically involving PtdIns(4,5)P2 and the phosphatase INPP5K, in regulating CD19 signaling.

Main Results:

  • CD19 acts as a molecular rheostat, where deficiency or overexpression leads to immune dysfunction.
  • A novel regulatory mechanism involving conformational control of the CD19 cytoplasmic domain was identified.
  • Ionic interactions between the CD19 cytoplasmic juxtamembrane region and PtdIns(4,5)P2 influence CD19 activation state.
  • Loss of INPP5K increases PtdIns(4,5)P2, causing constitutive CD19 signaling, impaired B-cell development, and hypogammaglobulinemia.

Conclusions:

  • Lipid-protein interactions play a critical role in restraining inappropriate CD19 activation.
  • Understanding CD19 regulation is vital for optimizing therapeutic strategies targeting B-cell malignancies and autoimmune diseases.
  • CD19 is a validated therapeutic target, with ongoing advancements in CAR T cells, bispecific antibodies, and monoclonal antibodies.